Related Experiment Video
Updated: Jun 27, 2026

07:13
Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992
R A Wermers1, S Khosla, E J Atkinson
1Mayo Clinic, Rochester, Minnesota, USA.
Annals of Internal Medicine
|March 15, 1997
Summary
The incidence of primary hyperparathyroidism sharply increased with routine calcium testing in the 1970s but has since progressively decreased, indicating an unexpected epidemiological shift for this endocrine disorder.
Area of Science:
- Endocrinology
- Epidemiology
- Public Health
Background:
- Routine serum calcium measurement introduction in the 1970s led to a surge in primary hyperparathyroidism diagnoses.
- The study examines trends in primary hyperparathyroidism incidence since the mid-1970s.
Purpose of the Study:
- To evaluate the incidence trends of primary hyperparathyroidism.
- To understand the epidemiological changes in primary hyperparathyroidism since the mid-1970s.
Main Methods:
- Population-based descriptive study conducted in Rochester, Minnesota, from 1965 to 1992.
- Identified definite cases of primary hyperparathyroidism using the Rochester Epidemiology Project medical records linkage system.
- Calculated age- and sex-adjusted incidence rates standardized to the 1990 US white population.
Main Results:
- Incidence rose from 15 to 112 cases per 100,000 person-years after routine calcium testing began in 1974.
- Despite improved case ascertainment, incidence significantly decreased to 4 cases per 100,000 person-years by 1992.
- Complications and survival rates remained unchanged, with no significant change in maximum serum calcium levels.
Conclusions:
- The observed progressive decrease in primary hyperparathyroidism incidence is unexpected.
- This trend suggests a significant shift in the disease's epidemiology.
Related Concept Videos
Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
The Parathyroid Glands
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

